Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Drug Therapy01:28

Drug Therapy

449
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
449
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

813
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
813
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

611
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
611
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

423
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
423

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Securing the Future for a Major Academic Cardiovascular Program: Hardwiring a Referral Network and Preparing for a Transition to Value-Based Reimbursement.

Hospital topics·2020
Same author

Managing Cardiovascular Risk Factors without Medications: What is the Evidence?

Cardiovascular & hematological agents in medicinal chemistry·2020
Same author

Inflammation May be the Future of Cardiovascular Risk Reduction: Does Colchicine have a Current Indication?

American journal of cardiovascular drugs : drugs, devices, and other interventions·2020
Same author

Alcohol Excess Is an Insufficiently Considered Cause of Malignant Refractory Hypertension.

Angiology·2019
Same author

The Superior Mesenteric Artery: From Syndrome in the Young to Vascular Atherosclerosis in the Old.

Cardiovascular & hematological agents in medicinal chemistry·2019
Same author

Imaging Characteristics and Significance of Coronary Artery Mismatch Lesions.

Angiology·2019

Related Experiment Video

Updated: May 3, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K

Problems and possible solutions for therapy with statins.

Thomas F Whayne1

  • 1Division of Cardiovascular Medicine, Department of Medicine (Cardiology), Gill Heart Institute, University of Kentucky, Lexington, Kentucky.

The International Journal of Angiology : Official Publication of the International College of Angiology, Inc
|January 18, 2014
PubMed
Summary

Statins offer significant cardiovascular benefits, especially for high-risk patients, despite potential side effects like myopathy. Healthcare providers should manage concerns and tailor statin therapy for optimal outcomes.

Keywords:
cognitioncoronary heart diseasediabetes mellitusliver inflammationlow-density lipoprotein cholesterolstatin myopathywomen and heart disease

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.2K
Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol
10:12

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol

Published on: March 25, 2020

5.6K

Related Experiment Videos

Last Updated: May 3, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.2K
Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol
10:12

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol

Published on: March 25, 2020

5.6K

Area of Science:

  • Cardiology
  • Pharmacology
  • Preventive Medicine

Background:

  • Statins are widely prescribed for cardiovascular risk reduction.
  • Concerns exist regarding their efficacy, side effects, and appropriate patient selection.

Purpose of the Study:

  • To evaluate the overall benefit-risk profile of statins in various patient populations.
  • To provide guidance on managing statin-related concerns and optimizing therapy.

Main Methods:

  • Review of existing clinical evidence and guidelines.
  • Analysis of statin efficacy and safety data across different cardiovascular risk strata.
  • Consideration of specific patient groups, including women, those with diabetes, and individuals experiencing side effects.

Main Results:

  • High cardiovascular risk patients derive substantial benefit from statins, outweighing potential risks.
  • Statin-related myopathy occurs but can often be managed through dosage adjustments or alternative statins.
  • Evidence supports statin use in women for both primary and secondary prevention.
  • Low-density lipoprotein cholesterol (LDL-C) remains a valid therapeutic target.
  • Liver inflammation and cognitive effects are generally minimal concerns.
  • Cardiovascular benefits of statins in patients with diabetes mellitus (DM) significantly outweigh the increased risk of DM incidence.

Conclusions:

  • Statins are a valuable medical intervention for appropriate patients, particularly those at high cardiovascular risk.
  • Practitioners must be informed about potential issues and adept at managing them to ensure adherence and efficacy.
  • Personalized therapy and ongoing risk assessment are crucial for maximizing the benefits of statin treatment.